BIOCITECH AND NEUILLY SUR SEINE, France - Oct. 8th, 2007 – Cellectis SA, the French rational genome engineering company, today announced the signature of an agreement with Laboratoires Servier on the engineering of industrial cell lines for use in pharmaceutical research and development.
